Haemonetics (HAE) Long-Term Deferred Tax (2010 - 2026)

Haemonetics' Long-Term Deferred Tax history runs 17 years deep, the most recent figure standing at $9.5 million for Q1 2026.

• On a quarterly basis, Long-Term Deferred Tax rose 22.02% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 22.02% increase from a year earlier, with the FY2026 full-year figure at $9.5 million, up 22.02% from the prior year.
• Long-Term Deferred Tax improved to $9.5 million in Q1 2026 per HAE's latest filing, from $7.3 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $9.5 million in Q1 2026 and bottomed at $4.3 million in Q4 2022.
• The 5-year median for Long-Term Deferred Tax is $6.7 million (2022), against an average of $6.6 million.
• Across the five-year window, Long-Term Deferred Tax dropped 29.39% in 2022 and jumped 92.18% in 2024, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $4.8 million in 2022, then increased by 4.71% to $5.1 million in 2023, then jumped by 57.79% to $8.0 million in 2024, then decreased by 8.39% to $7.3 million in 2025, then increased by 29.91% to $9.5 million in 2026.
• Per Business Quant, the three latest HAE Long-Term Deferred Tax figures stand at $9.5 million (Q1 2026), $7.3 million (Q4 2025), and $7.6 million (Q3 2025).